Supportive of a potential fear modulating role for glucagon, type II diabetes patients, which have both elevated insulin and glucagon levels (Cryer, 2012), have an increased risk to develop anxiety disorders (OR = 1.25 (CI 1.10–1.39) [18]). This evidence concerns the gene GCG and anxiety disorder.